These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26093594)

  • 1. [Cognitive dysfunctions caused by excessive exposure to manganese compounds. Cognitive disturbances in intravenous users of ephedrone (methcathinone) with manganese compounds].
    Kałwa A; Habrat B
    Psychiatr Pol; 2015; 49(2):305-14. PubMed ID: 26093594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Encephalopathy caused by intravenous potassium permanganate used for illegal production of methcathinone (ephedrone) from medicines containing pseudoephedrine].
    Habrat B; Baran-Furga H; Sienkiewicz-Jarosz H; Sein Anand J; Poniatowska R
    Przegl Lek; 2013; 70(8):613-6. PubMed ID: 24466704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic of neuropsychological deficits in patients diagnosed with manganese encephalopathy due to ephedrone use - case series analysis.
    Kałwa A
    Psychiatr Pol; 2020 Apr; 54(2):359-380. PubMed ID: 32772066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.
    Selikhova M; Fedoryshyn L; Matviyenko Y; Komnatska I; Kyrylchuk M; Krolicki L; Friedman A; Taylor A; Jäger HR; Lees A; Sanotsky Y
    Mov Disord; 2008 Nov; 23(15):2224-31. PubMed ID: 18785245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism.
    Djamshidian A; Sanotsky Y; Matviyenko Y; O'Sullivan SS; Sharman S; Selikhova M; Fedoryshyn L; Filts Y; Bearn J; Lees AJ; Averbeck BB
    Addiction; 2013 Apr; 108(4):771-9. PubMed ID: 23228208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ephedron dependence--case report].
    Myślicka D; Zuk M; Dziurkowski M
    Psychiatr Pol; 2011; 45(1):79-85. PubMed ID: 21614834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity following chronic intravenous use of "Russian cocktail".
    Varlibas F; Delipoyraz I; Yuksel G; Filiz G; Tireli H; Gecim NO
    Clin Toxicol (Phila); 2009 Feb; 47(2):157-60. PubMed ID: 18608260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Parkinsonian syndrome in methcathinone users and the role of manganese.
    Stepens A; Logina I; Liguts V; Aldins P; Eksteina I; Platkājis A; Mārtinsone I; Tērauds E; Rozentāle B; Donaghy M
    N Engl J Med; 2008 Mar; 358(10):1009-17. PubMed ID: 18322282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cognitive characteristics of patients developing manifestations of parkinsonism secondary to long-term ephedrone use.
    Koksal A; Keskinkılıc C; Sozmen MV; Dirican AC; Aysal F; Altunkaynak Y; Baybas S
    Eur Neurol; 2014; 71(3-4):208-12. PubMed ID: 24457624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese Encephalopathy Caused by Homemade Methcathinone (Ephedrone) Prevalence in Poland.
    Habrat B; Silczuk A; Klimkiewicz A
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese Encephalopathy among Ephedron Abusers.
    Janocha-Litwin J; Marianska K; Serafinska S; Simon K
    J Neuroimaging; 2015; 25(5):832-5. PubMed ID: 25255816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganic encephalopathy due to "ephedrone" abuse.
    Sanotsky Y; Lesyk R; Fedoryshyn L; Komnatska I; Matviyenko Y; Fahn S
    Mov Disord; 2007 Jul; 22(9):1337-43. PubMed ID: 17566121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse.
    Selikhova M; Tripoliti E; Fedoryshyn L; Matvienko Y; Stanetska H; Boychuk M; Komnatska I; Lees AJ; Sanotsky Y
    Clin Neurol Neurosurg; 2016 Aug; 147():71-7. PubMed ID: 27310289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible motor impairment in young addicts--ephedrone, manganism or both?
    Sikk K; Taba P; Haldre S; Bergquist J; Nyholm D; Zjablov G; Asser T; Aquilonius SM
    Acta Neurol Scand; 2007 Jun; 115(6):385-9. PubMed ID: 17511846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.
    de Bie RM; Gladstone RM; Strafella AP; Ko JH; Lang AE
    Arch Neurol; 2007 Jun; 64(6):886-9. PubMed ID: 17562938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.
    Sikk K; Taba P
    Int Rev Neurobiol; 2015; 120():257-71. PubMed ID: 26070761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism due to ephedrone neurotoxicity: a case report.
    Colosimo C; Guidi M
    Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409
    [No Abstract]   [Full Text] [Related]  

  • 18. Manganese concentration in patients with encephalopathy following ephedrone use: a narrative review and analysis of case reports.
    Ordak M; Sloniewicz N; Nasierowski T; Muszynska E; Bujalska-Zadrozny M
    Clin Toxicol (Phila); 2022 Jan; 60(1):10-17. PubMed ID: 34521308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report].
    Yildirim EA; Eşsizoğlu A; Köksal A; Doğu B; Baybaş S; Gökalp P
    Turk Psikiyatri Derg; 2009; 20(3):294-8. PubMed ID: 19757228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The histopathology of ephedrone drug abuse].
    Pigolkin IuI; Sherstiuk BV
    Sud Med Ekspert; 1996; 39(4):26-8. PubMed ID: 9026962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.